Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Yusuke Kunimatsu"'
Autor:
Yusuke Kunimatsu, Yukari Kano, Rei Tsutsumi, Izumi Sato, Mai Tanimura, Keiko Tanimura, Takayuki Takeda
Publikováno v:
Respirology Case Reports, Vol 11, Iss 4, Pp n/a-n/a (2023)
Abstract The incidence rate of pseudoprogression during immune checkpoint inhibitor monotherapy for non‐small cell lung cancer is reportedly 3.6%–6.9%, while pseudoprogression during chemoimmunotherapy is rare. Reports on pseudoprogression during
Externí odkaz:
https://doaj.org/article/1a939b57ffc741449f2b38c3af8fe906
Autor:
Rei Tsutsumi, Nobutaka Kataoka, Yusuke Kunimatsu, Izumi Sato, Mai Tanimura, Takayuki Nakano, Keiko Tanimura, Takayuki Takeda
Publikováno v:
Respirology Case Reports, Vol 10, Iss 7, Pp n/a-n/a (2022)
Abstract Large‐cell neuroendocrine carcinomas (LCNECs), categorized as high‐grade neuroendocrine carcinomas, account for approximately 3% of resected lung cancers. LCNECs containing other components are called ‘combined LCNECs’ and have no st
Externí odkaz:
https://doaj.org/article/f4f1ccb2e3f24b95bddac24efb9d993e
Autor:
Mai Tanimura, Nobutaka Kataoka, Yusuke Kunimatsu, Rei Tsutsumi, Izumi Sato, Takayuki Nakano, Keiko Tanimura, Takayuki Takeda
Publikováno v:
Respirology Case Reports, Vol 9, Iss 11, Pp n/a-n/a (2021)
Abstract Chromosomal rearrangements involving the c‐ros oncogene 1 (ROS1) are identified in approximately 1% of non‐small cell lung cancer (NSCLC) patients. Crizotinib is the first tyrosine kinase inhibitor (TKI) against ROS1‐rearranged NSCLC.
Externí odkaz:
https://doaj.org/article/a71ef66e406f4b3c9fd1f8500a7fcafe
Autor:
Nobutaka Kataoka, Yusuke Kunimatsu, Yusuke Tachibana, Takumi Sugimoto, Izumi Sato, Nozomi Tani, Yuri Ogura, Kazuki Hirose, Takayuki Takeda
Publikováno v:
Thoracic Cancer, Vol 11, Iss 9, Pp 2740-2742 (2020)
Atezolizumab was the first immune checkpoint inhibitor (ICI) to be introduced as a first‐line treatment option for extensive‐stage small cell lung cancer (ES‐SCLC), in combination with carboplatin and etoposide (CE) chemotherapy. However, SCLC
Externí odkaz:
https://doaj.org/article/0bc7e7692ec44664a67e5e5c20550310
Autor:
Yukari Kano, Nobutaka Kataoka, Yusuke Kunimatsu, Rei Tsutsumi, Izumi Sato, Mai Tanimura, Takayuki Nakano, Keiko Tanimura, Takayuki Takeda
Publikováno v:
Medicina, Vol 58, Iss 6, p 706 (2022)
Pulmonary pleomorphic carcinoma (PPC) is well-known for its aggressive nature that is usually resistant to platinum-based chemotherapy. On the other hand, the efficacy of an immune checkpoint inhibitor-based regimen in PPC has been elucidated. PPCs h
Externí odkaz:
https://doaj.org/article/450eb51b372140e984934296609bcd17
Drug‐induced interstitial lung disease associated with dasatinib coinciding with active tuberculosis
Publikováno v:
Respirology Case Reports, Vol 8, Iss 7, Pp n/a-n/a (2020)
Abstract A 69‐year‐old woman was diagnosed with a breakpoint cluster region‐Abelson‐positive chronic myeloid leukaemia and treated with dasatinib for 14 months. She presented with one month of high‐grade fever and persistent dry cough. Ches
Externí odkaz:
https://doaj.org/article/f9a72aa38f51409b9cd20c36953df21d
Publikováno v:
Respirology Case Reports, Vol 8, Iss 7, Pp n/a-n/a (2020)
Abstract Immunoglobulin G4 (IgG4)‐related disease (IgG4‐RD) is a systemic immune‐mediated, fibroinflammatory disorder categorized as proliferative or fibrotic depending on the responsiveness of corticosteroid treatment. IgG4‐related lung dise
Externí odkaz:
https://doaj.org/article/4555bbac4f6141808cccf7f1b5a5f104
Publikováno v:
Respirology Case Reports, Vol 8, Iss 3, Pp n/a-n/a (2020)
Abstract Vogt–Koyanagi–Harada disease (VKHD) is a rare systemic granulomatous autoimmune disease that affects melanocyte‐rich organs such as eye, inner ear, meninges, skin, and hair. VKHD leads to chronic uveal inflammation accompanied by a dec
Externí odkaz:
https://doaj.org/article/e21da7961bb547eaa274e25cf3e73fe1
Autor:
Nobutaka Kataoka, Yusuke Kunimatsu, Rei Tsutsumi, Nozomi Tani, Izumi Sato, Mai Tanimura, Takayuki Nakano, Keiko Tanimura, Daishiro Kato, Takayuki Takeda
Publikováno v:
Medicina, Vol 57, Iss 6, p 547 (2021)
Chemoimmunotherapy has become the standard of care as the first-line treatment of advanced or recurrent non-small-cell lung cancer (NSCLC). The bevacizumab-containing chemoimmunotherapy regimen is theoretically more effective than a non-bevacizumab-c
Externí odkaz:
https://doaj.org/article/4f857474ddc54fd5b16aced84a1a0a6b
Autor:
Izumi Sato, Hiroki Mizuno, Nobutaka Kataoka, Yusuke Kunimatsu, Yusuke Tachibana, Takumi Sugimoto, Nozomi Tani, Yuri Ogura, Kazuki Hirose, Takayuki Takeda
Publikováno v:
Medicina, Vol 56, Iss 8, p 403 (2020)
Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS) are life-threatening dermatologic adverse events in the same category, caused by a delayed-type drug hypersensitivity reaction. Although skin toxicity is common during treatment with
Externí odkaz:
https://doaj.org/article/9f55e5f45532405591d6a3d841432bf2